| ABCA1 | Binding cassette transporter A1 |
| ABTS | 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid), radical cation |
| ACC | Acetyl-CoA carboxylase |
| ACE | Antioxidant capacity equivalent |
| AD | Alzheimer’s disease |
| ALT | Alanine transaminase |
| AMPK | AMP-activated protein kinase |
| ARE | Antioxidant response element |
| AST | Aspartate transaminase |
| Aβ | Amyloid-β |
| BBB | Blood–brain barrier |
| BCAAs | Branched-chain amino acids |
| Bcl-2 | B-cell lymphoma 2 |
| BDNF | Brain-derived neurotrophic factor |
| BUN | Blood urea nitrogen |
| CAT | Catalase |
| C57BL/6J | Strain of mice used as a universal model for studying diet-induced obesity |
| CD36 | Scavenger receptor involved in cholesterol uptake |
| CDKs | Cyclin-dependent kinases |
| CKD | In chronic kidney disease |
| COX-2 | Cyclooxygenase-2 |
| DHT | Dihydrotestosterone |
| DNA | Deoxyribonucleic acid |
| DPPH | 2,2-diphenyl-1-picrylhydrazyl, radical |
| ESRD | End-stage renal disease |
| ERK1/2 | Extracellular signal-regulated kinase 1/2 |
| ER | Endoplasmic reticulum |
| FAO | Food and Agriculture Organization |
| FAS | Fatty acid synthase |
| FcεRI | The high-affinity receptor for the Fc region of immunoglobulin E |
| FoxO | Forkhead box O |
| GAE | Gallic acid equivalent |
| GSH-Px | Glutathione peroxidase |
| HDL-C | High-density lipoprotein cholesterol |
| HepG2 | Human liver cell line |
| HMG-CoA reductase | 3-hydroxy-3-methylglutaryl-CoA reductase |
| HO-1 | Heme oxygenase-1 |
| IgE | Immunoglobulin E |
| IKKα | Kinase α |
| IL-1 | Interleukin 1 |
| IL-1β | Interleukin-1 beta |
| IL-10 | Interleukin-10 |
| IL-6 | Interleukin 6 |
| iNOS | Nitric oxide synthase |
| JNK | c-Jun N-terminal kinase |
| LCAT | Lecithin:cholesterol acyltransferase |
| LDL | Low-density lipoprotein |
| LDL-C | Low-density lipoprotein cholesterol |
| LOX | Lipoxygenase |
| LPS | Lipopolysaccharides |
| LXRα | Liver X receptor alpha |
| MAPK | p38 mitogen-activated protein kinase |
| MDA | Malondialdehyde |
| MMP | Mitochondrial membrane potential |
| mTOR | Mechanistic target of rapamycin |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide |
| NAFLD | Non-alcoholic fatty liver disease |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NSCLC | Non-small cell lung cancer |
| p53 | Tumor protein, regulatory protein that is often mutated in human cancers |
| PI3K-PKB | Signaling pathway |
| PPAR-γ | Peroxisome proliferator-activated receptor gamma |
| PUFAs | Polyunsaturated fatty acids |
| PXR | Pregnane X receptor |
| ROS | Reactive oxygen species |
| SAMP8 | Senescence-accelerated mouse-prone 8 |
| SCFAs | Short-chain fatty acids |
| SOD | Superoxide dismutase |
| SR-A | Scavenger receptor class A |
| SR-BI | Scavenger receptor class B type I |
| SREBP-1c | Sterol regulatory element-binding protein 1c |
| SIRT1 | Sirtuin 1 |
| TLR4 | S gene-encoding Toll-like receptor 4 in humans |
| TNF-α | Tumor necrosis factor-alpha |
| UVB | Ultraviolet B |